|
|
|
||||||||||||
|
|
|
NEWS & EVENTS: Media Coverage
In Vivo Start Up – June 2011
Promedior Inc.: Advancing a pentraxin platform against fibrosis
BioCentury – September 6, 2010
Promedior avoids redundancy
SciBX Science Business eXchange – December 3, 2009
SAPing fibrosis
FierceBiotech – February 8, 2008
Emerging Drug Developer - Little Promedior aims big in new approach to fibrosis
Science Daily – January 19, 2007
Breakthrough Could Prevent Multiple Fibrotic Diseases: Tests Find Protein Stops
Fibrosis In Lung, Heart, Other Tissues
Silicon Valley / San Jose Business Journal – September 5, 2006
Morgenthaler Co-leads $7M Trellis Spin-off's Funding
[ back to top ]
|
|
|
|
Fibrosis is the common pathway in virtually all forms of chronic organ failure, including kidney, liver, lung and heart failure. Fibrotic organ failure affects more than 20 million people in the US alone. |
|
|
|
|
|
|
|
|
|